ARCHIVES

NCI Goofs On Contract Notice, Won’t Change Improper Deadline

This article is from The Cancer Letter archive.

Vol. 03 No. 15 | April 15, 1977

Download PDF Visit The Full Archive

Related Articles

SEC Investigating Bristol-Myers’ Sales Statements

July 12, 2002

NIH Plans Consensus Conference On Ovarian Cancer April 5-7

January 28, 1994

Auditor Raymond Weiss Finds “Incredible” Protocol Violations–26% Of Patients Were Ineligible For C225 Study

June 21, 2002

Report Urges Enhancement Of Cancer Data Systems.

October 20, 2000

FDA News: Rule On Youth Tobacco Sales In Effect Feb. 28

February 21, 1997

Georgetown-Hackensack Consortium Plan Points to Rising Value of NCI Designation

April 19, 2013